When my stepmom's Non-Hodgkin lymphoma relapsed, she qualified to be a recipient of a CAR-T therapy clinical trial at VICC. Our family met Brittney on the first day as she explained the clinical trial, the impact of CAR-T, and what we could expect as next steps.

From day one, Brittney was our main contact with the most loving heart and the ability to share complex information that we could all understand. Over the next 2 years, Brittney provided comfort, explanation, and coordination of care with the CAR-T Team. Our family is forever grateful for the beautiful comfort and love she shared.